Advisory Board


Katherine Andersen is a senior market manager covering Healthcare Corporate Finance in the U.S. in addition to the East and Central regions for SVB’s national Life Science practice. She sits on the Board of Directors for SVB's China JV. Prior to SVB, Katherine was a Senior Vice President for Wells Fargo Bank leading the Life Sciences business development and relationship management efforts for the New England region. Before that, she was a Director at Wells Fargo Capital Finance focused on front-end business development and underwriting of structured loans, ultimately totaling over $3.0B in commitments. Prior to Wells, she held various positions across mergers and acquisitions, finance, equity derivatives, audit, and management while at Affiliated Managers Group, Merrill Lynch, GE Corporate Audit Staff and GE Capital. Katherine has a bachelor’s degree in finance and economics from Virginia Tech. She has also completed Dartmouth’s Tuck Executive Leadership and Strategic Impact Program, Wells Fargo’s Transformational Leadership Program, the Program on Negotiation at Harvard Law School and the GE Capital Financial Management Program. Away from work, Katherine serves on the Finance Advisory Board for Virginia Tech and the Corporate Council for the American Cancer Society’s Hope Lodge. She also enjoys endurance sports, traveling the world with her family, and baking epic birthday cakes for her three kids.



Abigail Bracha is Chief of Staff at Rubius Therapeutics. Prior to joining Rubius, Abby founded and led the global strategy, search and evaluation team for GE Healthcare Life Sciences. In this role, she was responsible for developing the growth strategy and technology innovation roadmap for GE’s life sciences tools business. Prior to GE Healthcare, Abby was at GE Ventures.  She also spent several years at Dell-EMC where she covered emerging digital technologies. Abby holds a BA in Statistics with General Honors from the University of Chicago, which she completed in three years, and holds a PhD from Harvard University in Experimental Pathology. She was a National Science Foundation Graduate Research Fellow and received support from the Howard Hughes Medical Institute.



Alison Elworthy is the VP of Customer Success at HubSpot. Prior to that, she was VP and Chief of Staff and was responsible for HubSpot's operating system, strategic planning and execution, and ultimately, keeping the company on track as the world's leading inbound marketing and sales platform. Before that, Alison led various functions at HubSpot as Marketing Operations Manager, Sales Operations Senior Manager, and Director of Operations. She was previously a User Experience Specialist at Fidelity Investments, focused on the customer experience of their business and customer facing products and websites. Outside of work, she is a wine and food enthusiast and mom to her 2 year old son and newborn daughter. She holds a BS in Human Factors Engineering from Tufts University and an MBA from the Tuck School of Business at Dartmouth.



Natasha Engan - As Deltek's Senior Vice President of Global Consulting, Natasha Engan is responsible for leading the company’s services business, Deltek Global Consulting. A 20+-year veteran of the software and services business, Natasha has a strong background in managing cross-functional, customer-facing teams in a global workforce. Before Deltek, she held various leadership positions at IBM, including VP of Security Financial Services Market and Security Sales, and VP of North American Cloud Services. Among other roles, Natasha was responsible for IBM cyber security services and software for the evolving threat landscapes in the Financial Services Market. She also had executive management responsibilities for IBM's cloud services businesses, including strategy, market selection, day-to-day sales, P&L management, partner strategy and customer satisfaction. Prior to working at IBM, Natasha held other global sales and services positions at Ascential Software and consulted to early stage technology companies. Natasha graduated from Mount Holyoke College and the Executive Program at Louisiana State University.


 

Jon Giebel has almost 10 years of experience in the agbiotech sector with Bayer.  Most of his career Jon worked in Bayer’s CropScience business, leading a team of scientists focused on isolating and culturing environmental microbes for insecticidal toxin discovery.  In addition to his roles in new trait discovery, he has served in global strategy roles for R&D and supported the integration of Bayer and Monsanto.  In his current role as Program Lead for Bayer’s LifeHub Boston, Jon is responsible for leading a cross divisional open innovation space with a goal of leveraging the strong innovation ecosystem in Cambridge and Boston.  The LifeHub Boston strives to convene diverse communities and creative thought leaders to explore solutions to complex challenges in the fields of health and nutrition.  Jon also serves on the Advisory Board for the WEST (Women in the Enterprise of Science & Technology) organization and is passionate about community outreach activities that advance Bayer’s core mission statement, Science for a Better Life. He has authored 9 scientific papers and is a named inventor on multiple US patents.  He has a Ph.D. in Microbiology from the University of Michigan, and a B.S. in Biology from Cornell University.

 


Elissa Hobert is a scientist at Moderna Therapeutics. She is focused on developing improved methods for delivering mRNA therapeutics. Prior to joining Moderna, Elissa was an NIH postdoctoral fellow at Harvard Medical School where she studied bioactive natural products produced by members of the gut microbiome. Elissa received her BS in chemistry from the University of Wisconsin – Madison and her PhD in chemistry from Yale University. She has volunteered at WEST events since 2015 and was the recipient of the WEST Giving Back Award in 2016.



Anna Li is a microbiologist at Warp Drive Bio where she is a key player in the genome mining platform of novel antibiotics. Prior to that Anna had worked at Organismal and Evolutionary Biology Department of Harvard University as a visiting scholar in 2013 and 2014 and conducted the research on mutational pathways of bacterial drug resistance. She received her Ph.D. in Plant Pathology in 2007 and had been an associate professor of Shandong agricultural University in China before she came to US. Anna has volunteered at WEST events and book clubs for many years and was the recipient of the WEST Giving Back Award in 2017.



Dr. Elizabeth O'Day is the CEO and Founder of Olaris Therapeutics, a pharmaceutical company that develops precision medicines for diseases with little to no treatment options and dismal survival rates. Dr. O'Day is also the Founder of Lizzard Fashion, an apparel company that uses fashion to promote science. Partial Lizzard proceeds support cancer research. Additionally, Dr. O'Day founded Proyecto Chispa (Project Spark), a 501c3 non-profit that recycles electronics and uses the resale of parts to build computer centers in orphanages throughout the world. Through her work at Proyecto Chispa, Dr. O'Day was selected as the Greenovate Champion of the Year by the Mayor of Boston in 2015. Dr. O’Day received her PhD from Harvard University, where she was a National Science Foundation fellow. She was one of eleven America scientists awarded a Winston Churchill fellowship and received a Master’s of Philosophy in Chemistry from the University of Cambridge. She has a Bachelors of Science degree from Boston College in Biochemistry. Dr. O’Day is also a Global Shaper at the World Economic Forum and was an invited speaker as a “new champion to reboot healthcare” at the annual meeting in Davos in 2016. She was also a "nominated change maker" and invited to attend the first ever United State of Women Summit convened by the White House in 2016. 


Greg Reid is the CEO of InFuture LLC, a consulting firm focused on data and information privacy implementations, including GDPR and HIPAA compliance strategies, for US companies. Greg’s clients are primarily in the life sciences, pharmaceutical and biotechnology industries where he works closely with the companies’ General Counsels, CIO’s, and Compliance Officers to support their data privacy initiatives and programs. Greg is ANSI-certified in US and EU data protection and privacy regulations and has earned an MBA in Financial Accounting, and Corporate and Investment Finance, an MS in Chemical Engineering, and a Master of Jurisprudence in Healthcare Regulatory and Life Sciences Law. He holds 15 US and global patents for content and document management systems and is former Partner with Accenture and Principal with EY.